Advertisement

Overview of Cerebrovascular Disease: Role of the Endothelium

  • Allan D. Callow
Part of the NATO ASI Series book series (NSSA, volume 294)

Abstract

The circulation of the brain differs from that of other organs in several respects, most notably by the rigorous application of the universal principle that the volume of blood entering an organ cannot exceed that which exits. Unlike other solid organs, the brain is confined within a non-resilient, rigid, bony box — the skull. Parenchymatous organs such as the spleen, kidney, liver and the abdominal viscera, even the skeletal musculature, have the capacity to accommodate transient changes in blood volume and blood pressure. Not so for the brain. An increase in brain volume causes brain substance to press against the unyielding skull and, in severe instances, to seek egress through various channels called foramina — portals via which nerves exit, and blood vessels enter and also exit the cranium. The largest of these channels is the foramen magnum, the pathway for the spinal cord. Literally, the brain is forced out of the skull by the build-up of pressure within it. This is known as herniation of the brain. It is accompanied by loss of consciousness and, if unchecked, may progress to coma and death. Lesser degrees of intracranial pressure while not fatal, result in compromise of neuronal function.

Keywords

Giant Cell Arteritis Moyamoya Disease Cerebral Autoregulation Pulseless Disease Polyarteritis Nodosa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Callow, A.D. and Ernst, C.B. Eds. Vascular Surgery: Theory and Practice, Stamford, CT: Appleton & Iaange, 1995.Google Scholar
  2. 2.
    Callow, A.D. Surgery of the Carotid and Vertebral Arteries for the Prevention of Stroke, Baltimore, MD: Williams & Wilkins, 1996.Google Scholar
  3. 3.
    Kissel, J.T. Neurologic manifestations of vasculitis. In: Neurologic Manifestations of System Disease. Neurologic Clinics, 7:655–673, 1989.Google Scholar
  4. 4.
    Launes, J., Livanainen, M., Erkininjuntti, T. et al. Isolated angiitis of the central nervous system. Acta. Neurol. Scand., 74:108, 1986.CrossRefPubMedGoogle Scholar
  5. 5.
    Shimizu, K. and Sano, K. Pulseless disease. J. Neuropathol. Clin. Neurol., 1:37–47, 1951.Google Scholar
  6. 6.
    Ishikawa, K. and Yonekawa, Y. Regression of carotid stenosis after corticosteroid therapy in occlusive thromboaortopathy (Takayasu’s disease). Stroke, 18:677–679, 1987.CrossRefPubMedGoogle Scholar
  7. 7.
    Shelhamer, J.H., Volkman, D.J., and Parrillo, J.E. Takayasu’s arteritis and its therapy. Ann. Int. Med., 103:121–126, 1985.CrossRefPubMedGoogle Scholar
  8. 8.
    Yamamoto, S., Ogawa, S., Kitano, T., et al. Complete evaluation of the cardiovascular lesions in 24 patients with Takayasu’s aortitis using four-image, intravenous digital subtraction angiography. Am. Heart J., 114:1426–1431, 1987.CrossRefPubMedGoogle Scholar
  9. 9.
    Derby, B.M. and Cravioto, H.M. Cerebral arteritis. In: Cerebrovascular Surgery, Vol. II, Fein, J.M. and Flamm, E.S. eds. New York: Springer Verlag, 1985.Google Scholar
  10. 10.
    Bengtsson, B.A. Incidence of giant cell arteritis. Acta. Med. Scand. (Suppl), 658:15–17, 1987.Google Scholar
  11. 11.
    Caselli, R.J., Hunder, G.O., and Whisnant, J.R. Neurologic disease in biopsy-proven giant cell temporal arteritis. Neurol., 38:352–359, 1988.CrossRefGoogle Scholar
  12. 12.
    Suzuki, J. and Takaku, A. Cerebrovascular “moyamoya” disease: Disease showing abnormal net-like vessels in the base of the brain. Arch. Neurol., 20:288–289, 1969.CrossRefPubMedGoogle Scholar
  13. 13.
    Yonekawa, M.D., Handa, H., and Okuno, T. Moyamoya disease: diagnosis, treatment and recent achievement. In: Stroke: Pathophysiology, Diagnosis and Management, Vol. 2, Barnett, H., Stein, B., Mohr, J., and Yatsu, E. eds. New York: Churchill Livingstone, 1986.Google Scholar
  14. 14.
    Yamashita, M., Tanaka, K., Matsouo, T., et al. Cerebral dissecting aneurysms in patients with moyamoya disease. J. Neurosurg., 58:120–125, 1983.CrossRefPubMedGoogle Scholar
  15. 15.
    Havlik, R.J., Fried, I., Chyatte, D., and Modlin, I.M. Encephalo-mental synangiosis in the management of moyamoya disease. J. Neurosurg., 49:679–688, 1978.CrossRefGoogle Scholar
  16. 16.
    Olds, M.V., Griebel, R.W., Hoffman, H.J., Craven, M., et al. The surgical treatment of childhood moyamoya disease. J. Neurosurg., 66:675–680, 1987.CrossRefPubMedGoogle Scholar
  17. 17.
    Matsushima, Y., Fukai, N., Tanaka, K., et al. A new surgical treatment of moyamoya disease in children: a preliminary report. Surg. Neurol., 15:313–320, 1986.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Allan D. Callow
    • 1
  1. 1.Boston University School of Medicine and The Whitaker Cardiovascular InstituteBoston City Hospital and The University HospitalBostonUSA

Personalised recommendations